First-line obinutuzumab for follicular lymphoma

被引：0
|
作者：
Baker, Holly
机构：
来源：
LANCET ONCOLOGY | 2017年 / 18卷 / 11期
关键词：
D O I：
10.1016/S1470-2045(17)30781-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E648 / E648
页数：1
相关论文
共 50 条
  • [31] Minimal Residual Disease in Patients with Follicular Lymphoma Treated with Obinutuzumab or Rituximab As First-Line Induction Immunochemotherapy and Maintenance in the Phase 3 GALLIUM Study
    Pott, Christiane
    Hoster, Eva
    Kehden, Britta
    Unterhalt, Michael
    Herold, Michael
    van der Jagt, Richard H.
    Janssens, Ann
    Kneba, Michael
    Mayer, Jiri
    Pocock, Chris
    Danesi, Nathalie
    Fingerle-Rowson, Gunter
    Harbron, Chris
    Mundt, Kirsten
    Marcus, Robert E.
    Hiddemann, Wolfgang
    BLOOD, 2016, 128 (22)
  • [32] Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma-a real-world multicenter retrospective cohort study
    Berger, Tamar
    Shochat, Tzippy
    Aumann, Shlomzion
    Nachmias, Boaz
    Goldschmidt, Neta
    Horesh, Nurit
    Harel, Reut
    Aviv, Ariel
    Shmerts, Ella
    Abadi, Uri
    Shimony, Shai
    Raanani, Pia
    Gafter-Gvili, Anat
    Gurion, Ronit
    ANNALS OF HEMATOLOGY, 2023, 102 (08) : 2127 - 2136
  • [33] Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma: An Evidence Review Group Evaluation of the NICE Single Technology Appraisal
    Thielen, Frederick W.
    Bueyuekkaramikli, Nasuh C.
    Riemsma, Rob
    Fayter, Debra
    Armstrong, Nigel
    Wei, Ching-Yun
    Carrera, Vanesa Huertas
    Misso, Kate
    Worthy, Gill
    Kleijnen, Jos
    Ramos, Isaac Corro
    PHARMACOECONOMICS, 2019, 37 (08) : 975 - 984
  • [34] Obinutuzumab Plus Chemotherapy As First Line Treatment in Patients with Follicular Lymphoma: Experience from a Community Hospital
    de Una, Soraya Lorente
    Gutierrez, Javier
    Gonzalez, Matilde
    Kumar, Anjana
    Morales, Elena
    Herrada, Juan
    BLOOD, 2022, 140 : 12001 - 12001
  • [35] Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma
    Cencini, Emanuele
    Fabbri, Alberto
    Schiattone, Luana
    Bartalucci, Giulia
    Bocchia, Monica
    LEUKEMIA & LYMPHOMA, 2015, 56 (10) : 2997 - 2998
  • [36] SINGLE AGENT RITUXIMAB IS A VALID OPTION FOR FIRST-LINE TREATMENT IN FOLLICULAR LYMPHOMA
    Ghielmini, M.
    ANNALS OF ONCOLOGY, 2011, 22 : 81 - 81
  • [37] Patterns Of First-Line Management Strategies In Older Adults With Follicular Lymphoma (FL)
    Rai, Ashish
    Nastoupil, Loretta J.
    Williams, Jessica N.
    Lipscomb, Joseph
    Ward, Kevin
    Howard, David H.
    Flowers, Christopher R.
    BLOOD, 2013, 122 (21)
  • [38] Rituximab Maintenance Therapy After First-Line induction Chemoimmunotherapy for Follicular Lymphoma
    Hilal, Talal
    Leis, Jose F.
    Reeder, Craig B.
    JAMA ONCOLOGY, 2018, 4 (06) : 859 - 860
  • [39] First-line treatment of follicular lymphoma-a patient-oriented algorithm
    Feuerlein, Kristin
    Zucca, Emanuele
    Ghielmini, Michele
    LEUKEMIA & LYMPHOMA, 2009, 50 (03) : 325 - 334
  • [40] Contempo: Preliminary Results in First-Line Treatment of Follicular Lymphoma with the Oral Dual PI3K-δ,γ Inhibitor, Duvelisib, in Combination with Rituximab or Obinutuzumab
    Casulo, Carla
    Sancho, Juan-Manuel
    Van Eygen, Koen
    de Vos, Sven
    Mercadal, Santiago
    Johnson, Roderick J.
    Bouabdallah, Kamal
    Holmes, Houston
    Lemmens, Jan
    Gyan, Emmanuel
    Merli, Michele
    Advani, Ranjana H.
    Steelman, Lori
    Pearlberg, Joseph
    Goy, Andre
    BLOOD, 2016, 128 (22)
12345